Procedure with SR18662 drastically decreases growth and proliferation of CRC cells. SR18662 reveals enhanced efficacy in decreasing viability of several CRC mobile traces. Circulation cytometry Examination next SR18662 treatment method shows a rise in cells captured in possibly S or G2/M phases on the mobile cycle and a significant boost in the qua… Read More